Abstract
We report a case of multiple dermatofibromas in a patient with systemic lupus erythematosus (SLE) and Sjögren’s syndrome. He was treated with prednisolone, diaphenylsulfone, and cyclosporine for SLE. He noticed two brown nodules on his right lower leg 3 years after the first consultation. Subsequently, six nodules developed within 6 months, and 2 more nodules after 10 months. Histopathological examination of a nodule on his left hand showed fibrotic proliferation with a storiform pattern in the whole dermis, but neither necrosis nor mitosis was observed. From these findings, a diagnosis of multiple dermatofibromas was made. As these tumors appeared during the remission stage of SLE, they might have been under immunosuppressive conditions caused by immunosuppressing agents rather than collagen disease itself.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baraf CS, Shapiro L. Multiple histiocytomas. Arch Dermatol. 1970;101:588–90.
Newman DM, Walter JB. Multiple dermatofibromas in patients with systemic lupus erythematosus on immunosuppressive therapy. N Engl J Med. 1973;289:842–3.
Kuniyuki S, Shindow K. Multiple dermatofibromas accompanied by eruptive benign keratoses in a patient with systemic lupus erythematosus. J Dermatol. 1996;23:619–22.
Chohen PR. Multiple dermatofibromas in patients with autoimmune disorders receiving immunosuppressive therapy. Int J Dermatol. 1991;30:266–70.
Tsunemi Y, Tada H, Saeki H, Ihn H, Tamaki K. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren’s syndrome. Clin Exp Dermatol. 2004;29:483–5.
Yamamoto T, Katayama I, Nishioka K. Mast cell numbers in multiple dermatofibromas. Dermatology. 1995;190:9–13.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340–7.
Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren’s syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.
Bombardier C, Gladman DD, Urowitz MB, Carton D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630–40.
Ackerman AB. Dermatofibroma. In: Ackerman AB, editor. Histologic. Diagnosis of inflammatory skin diseases. 2nd ed. Baltimore: Williams & Wilkins; 1997. p. 279–81.
Cerio R, Spaull J, Jones EW. Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol. 1989;120:197–206.
Lin RY, Landsman L, Krey PR, Lambert WC. Multiple dermatofibromas and systemic lupus erythematosus. Cutis. 1986;37:45–7.
Bearcroft WGC, Amieson MF. An outbreak of subcutaneous tumors in rhesus monkey. Nature. 1958;182:195–6.
Yamamoto T, Katayama I, Nishioka K. Involvement of basic fibroblast growth factor in fibroblast-stimulatory serum activity of a patient with systemic lupus erythematosus and multiple dermatofibromas. Dermatology. 1995;191:281–5.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Fujisawa, T., Seishima, M. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren’s syndrome. Mod Rheumatol 20, 396–400 (2010). https://doi.org/10.1007/s10165-010-0281-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-010-0281-y